Skip to main content
. 2018 Oct 10;8(10):180086. doi: 10.1098/rsob.180086

Figure 6.

Figure 6.

Fibulin-5 expression is reversely linked with IDH1 mutation in patients with NSCLC. (a) WB analysis of IDH1 R132H in malignant specimens from 40 patients with NSCLC. (b) Representative IHC staining for IDH1 R132H in IDH1 WT and mutant IDH1 specimens. (c) 2-HG levels in malignant specimens from the 40 patients with NSCLC. (d) Fibulin-5 mRNA levels in malignant specimens from the 40 patients with NSCLC.